A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation

Study Identifier
191622-133
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact

Results Available

Protocol
Available Language(s): English
Statistical Analysis Plan
Available Language(s): English

Study Details

Medical Condition
  • Men's Health
  • Study Drug
  • OnabotulinumtoxinA
  • Normal Saline
  • Phase
    Phase 2
    Sex
    Male
    Age
    18 - 50 Years

    Protocol Summary

    This is a safety and efficacy study of OnabotulinumtoxinA for the treatment of premature ejaculation (PE) in male participants.

    Study Locations

    Location
    Status
    Location
    San Diego Sexual Medicine
    San Diego, California, United States, 92120
    Status
    Not applicable
    Location
    LA Biomedical Research Institute at Harbor-UCLA Medical Center
    Torrance, California, United States, 90502
    Status
    Not applicable
    Location
    Connecticut Clinical Research Center
    Middlebury, Connecticut, United States, 06762
    Status
    Not applicable
    Location
    Center for Marital and Sexual Health of South Florida
    West Palm Beach, Florida, United States, 33401
    Status
    Not applicable
    Location
    Tulane University School of Medicine
    New Orleans, Louisiana, United States, 70112
    Status
    Not applicable
    Location
    Manhattan Medical Research
    New York, New York, United States, 10016
    Status
    Not applicable
    Showing {first} - {last} of {total} Results